{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:26:46Z","timestamp":1791397606919,"version":"4.3.3"},"reference-count":23,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We report 3 cases of a previously uncharacterized form of histiocytosis presenting in early infancy and showing ALK immunoreactivity. The patients presented with pallor, massive hepatosplenomegaly, anemia, and thrombocytopenia. Liver biopsy showed infiltration of the sinusoids by large histiocytes with markedly folded nuclei, fine chromatin, small nucleoli, and voluminous lightly eosinophilic cytoplasm that sometimes was vacuolated or contained phagocytosed blood cells. One patient developed cutaneous infiltrates that morphologically resembled juvenile xanthogranuloma. The histiocytes were immunoreactive for histiocytic markers (CD68, CD163, lysozyme), S100 protein, ALK (membranous and cytoplasmic pattern), and dendritic cell markers (fascin, factor XIIIa), but not CD1a and langerin. One case successfully analyzed by molecular techniques revealed TPM3-ALK fusion. Thus the spectrum of diseases exhibiting ALK translocation should be expanded to include ALK+ histiocytosis. The disease in the 3 patients (2 having been given chemotherapy) resolved slowly over many months.<\/jats:p>","DOI":"10.1182\/blood-2008-03-147017","type":"journal-article","created":{"date-parts":[[2008,7,25]],"date-time":"2008-07-25T20:54:20Z","timestamp":1217019260000},"page":"2965-2968","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":136,"title":["ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy"],"prefix":"10.1182","volume":"112","author":[{"given":"John K. C.","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lamant","sequence":"additional","affiliation":[{"name":"Inserm, U563, Centre de Physiopathologie de Toulouse Purpan, and Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Algar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Melbourne, Australia; and"},{"name":"Children's Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Delsol","sequence":"additional","affiliation":[{"name":"Inserm, U563, Centre de Physiopathologie de Toulouse Purpan, and Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Y. W.","family":"Tsang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"King C.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tiedemann","sequence":"additional","affiliation":[{"name":"Children's Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung W.","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Melbourne, Australia; and"},{"name":"Department of Anatomical Pathology, Royal Children's Hospital, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111714055185500_B1","first-page":"513","article-title":"Disorders of histiocytes.","volume-title":"Hematopathology: A Volume in Foundations in Diagnostic Pathology Series","author":"Jaffe","year":"2007"},{"key":"2019111714055185500_B2","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood.V85.7.1977.bloodjournal8571977","article-title":"Histiocytes and histiocytosis.","volume":"85","author":"Favara","year":"1995","journal-title":"Blood"},{"key":"2019111714055185500_B3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pbc.20246","article-title":"Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses.","volume":"45","author":"Weitzman","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"2019111714055185500_B4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C","article-title":"Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic\/Reticulum Cell Proliferations: Reclassification Working Group of the Histiocyte Society.","volume":"29","author":"Favara","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"2019111714055185500_B5","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1182\/blood-2004-08-3296","article-title":"Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte\/natural killer cell functions.","volume":"105","author":"Ishii","year":"2005","journal-title":"Blood"},{"key":"2019111714055185500_B6","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/jmg.2005.035253","article-title":"Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies.","volume":"43","author":"Rudd","year":"2006","journal-title":"J Med Genet"},{"key":"2019111714055185500_B7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/07853890500465189","article-title":"Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives.","volume":"38","author":"Verbsky","year":"2006","journal-title":"Ann Med"},{"key":"2019111714055185500_B8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/humu.20274","article-title":"Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A.","volume":"27","author":"Zur Stadt","year":"2006","journal-title":"Hum Mutat"},{"key":"2019111714055185500_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","article-title":"Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.","volume":"41","author":"Pileri","year":"2002","journal-title":"Histopathology"},{"key":"2019111714055185500_B10","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood.V93.9.3088","article-title":"A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation.","volume":"93","author":"Lamant","year":"1999","journal-title":"Blood"},{"key":"2019111714055185500_B11","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1182\/blood-2005-06-2421","article-title":"SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling.","volume":"107","author":"Honorat","year":"2006","journal-title":"Blood"},{"key":"2019111714055185500_B12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer.","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2019111714055185500_B13","first-page":"3509","article-title":"Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.","volume":"94","author":"Falini","year":"1999","journal-title":"Blood"},{"key":"2019111714055185500_B14","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology.","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"2019111714055185500_B15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0002-9440(10)65629-5","article-title":"ALK expression defines a distinct group of T\/null lymphomas (\u201cALK lymphomas\u201d) with a wide morphological spectrum.","volume":"153","author":"Falini","year":"1998","journal-title":"Am J Pathol"},{"key":"2019111714055185500_B16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00000478-200106000-00007","article-title":"Anaplastic lymphoma kinase expression in inflammatory pseudotumors.","volume":"25","author":"Chan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"2019111714055185500_B17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","article-title":"A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation.","volume":"89","author":"Delsol","year":"1997","journal-title":"Blood"},{"key":"2019111714055185500_B18","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2003-03-0786","article-title":"ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.","volume":"102","author":"Gascoyne","year":"2003","journal-title":"Blood"},{"key":"2019111714055185500_B19","first-page":"2776","article-title":"Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.","volume":"59","author":"Griffin","year":"1999","journal-title":"Cancer Res"},{"key":"2019111714055185500_B20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/pbc.20540","article-title":"ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement.","volume":"46","author":"Isimbaldi","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"2019111714055185500_B21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am J Pathol"},{"key":"2019111714055185500_B22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"key":"2019111714055185500_B23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/7\/2965\/1303509\/zh801908002965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/7\/2965\/1303509\/zh801908002965.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T14:06:03Z","timestamp":1573999563000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/112\/7\/2965\/24786\/ALK-histiocytosis-a-novel-type-of-systemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-03-147017","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}